Differential long-term tamoxifen therapy benefit by menopausal status in breast cancer patients: secondary analysis of a controlled randomized clinical trial.
Saved in:
| Title: | Differential long-term tamoxifen therapy benefit by menopausal status in breast cancer patients: secondary analysis of a controlled randomized clinical trial. |
|---|---|
| Authors: | Johansson A; Department of Oncology and Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden.; Breast Center, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, 171 64 Stockholm, Sweden., Dar H; Department of Oncology and Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden.; Breast Center, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, 171 64 Stockholm, Sweden., Nordenskjöld A; Institution of Clinical Sciences, Department of Oncology, Sahlgrenska Academy, Gothenburg University, 413 45 Gothenburg, Sweden., Perez-Tenorio G; Department of Biomedical and Clinical Sciences and Department of Oncology, Linköping University, 581 83 Linköping, Sweden., Tobin NP; Department of Oncology and Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden.; Breast Center, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, 171 64 Stockholm, Sweden., Yau C; Buck Institute for Research on Aging, Novato, CA 94945, United States.; Department of Surgery, University of California San Francisco, San Francisco, CA 94115, United States., Benz CC; Buck Institute for Research on Aging, Novato, CA 94945, United States.; Department of Medicine, University of California San Francisco, San Francisco, CA 94115, United States., Esserman LJ; Department of Surgery, University of California San Francisco, San Francisco, CA 94115, United States., van 't Veer LJ; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA 94115, United States., Nordenskjöld B; Department of Biomedical and Clinical Sciences and Department of Oncology, Linköping University, 581 83 Linköping, Sweden., Stål O; Department of Biomedical and Clinical Sciences and Department of Oncology, Linköping University, 581 83 Linköping, Sweden., Fornander T; Department of Oncology and Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden., Lindström LS; Department of Oncology and Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden.; Breast Center, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, 171 64 Stockholm, Sweden. |
| Source: | Journal of the National Cancer Institute [J Natl Cancer Inst] 2025 May 01; Vol. 117 (5), pp. 868-878. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1460-2105 |
|---|---|
| DOI: | 10.1093/jnci/djae268 |
